• Schouw & Co. outlined 2030 targets of DKK 4.5 billion EBITDA and 15% ROIC at its 2026 capital markets day.
• BioMar’s listing generated approximately DKK 2.6 billion in net proceeds; the parent retains a 74% stake.
• GPV completed Enics’ integration; its 2030 targets include approximately DKK 15 million revenue, including acquisitions, with an EBITDA margin near 10%.
• HydraSpecma targets revenue above DKK 5 billion; its order book exceeded DKK 1 billion at the end of the first half of 2026.
• Spectre, acquired through a majority stake in 2026, targets 2030 revenue of DKK 1.7-2 billion with a 15-17% EBITDA margin.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Schouw & Co. A/S published the original content used to generate this news brief on October 15, 2026, and is solely responsible for the information contained therein.